Saba Capital sells ECAT shares in two February trades
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported two open-market sales of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported two open-market sales of common stock. On February 9, 2026, it sold 96,973 shares at $15.55 per share. On February 10, 2026, it sold a further 64,101 shares at $15.60 per share.
After these transactions, Saba Capital Management, L.P. indirectly beneficially owned 24,345,110 shares of ECAT common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 64,101 | $15.60 | $1000K |
| Sale | Common Stock | 96,973 | $15.55 | $1.51M |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did Saba Capital report for ECAT?
What was the second ECAT stock sale reported by Saba Capital?
What is Saba Capital’s relationship to BlackRock ESG Capital Allocation Term Trust (ECAT)?
Were the ECAT transactions reported as direct or indirect ownership changes?
AI-generated analysis. How Rhea-AI works. Not financial advice.